SMALL CELL LUNG CARCINOMA
Clinical trials for SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug (GV20-0251) combined with an immunotherapy (anti-PD-1) in people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. About 227 adults with various cancers, including lung, breast, and colorectal, will participa…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Blood test steers next move for lung cancer patients after standard therapy
Disease control Not yet recruitingThis study looks at people with limited-stage small cell lung cancer whose disease is under control after chemoradiation. A special blood test (MRD) checks for leftover cancer signals. Those with positive results get a combination of immunotherapy and anti-angiogenic drugs to try…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC